Full-Time

Laboratory Automation Platform Consultant

Posted on 8/27/2024

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Mid, Senior

Bridgewater Township, NJ, USA

Hybrid position requiring in-office presence.

Category
Lab & Research
Life Sciences
Medical Research
Requirements
  • B.S. required, Ph.D. preferred in technical discipline: engineering, science, or related field
  • 5-12 years of analytical or QC experience, CAR-T experience is highly desirable.
  • Experience in implementing and managing commercial analytical method improvements and changes
  • Experience in developing and implementing solutions with industry leading commercial analytical automation partners
  • Experience in integrating analytical methods into an automation platform
  • Candidate must have program management expertise in the life sciences field
  • Extensive experience in analytical automation technology and vendor offerings specific to commercial analytical platforms, liquid handling & sample handling systems
  • Extensive knowledge in analytical best practices, industry standards and the latest technologies
  • Ability to think critically and demonstrated troubleshooting and problem-solving skills.
  • Results driven with strong analytical, problem solving and critical thinking skills.
  • Strong experience working in a cross-functional organization with multiple partners with competing priorities.
  • Ability to plan, multitask, prioritize and be an effective and influential decision maker focused on action and implementation.
  • Knowledge of Elisa, Flow Cytometry, PCR (Preferred, not required)
Responsibilities
  • Provide technical and program management to drive an analytical automation platform solution for a best-in-class CAR-T product.
  • Development of an automation concept through detailed execution planning activities and milestone
  • Program management leadership to drive the strategic plans/business cases to support selected platform concept, detailed project schedule for implementation, vendor coordination and cross functional collaboration to ensure a seamless introduction in cGMP
  • Work collaboratively with internal and external partners to identify and drive implementation of industry leading automation solutions
  • Drives plans for modification of existing analytical methods and ensuring that all methods are able to be integrated into an analytical automation platform
  • Identifies and drives plans for new analytical technologies that result in paradigm shift in throughput and capacity

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
  • New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
  • Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

What critics are saying

  • Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
  • Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
  • Financial strain from new R&D facility could affect operational focus if advancements lag.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
  • Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

INACTIVE